home / stock / valn / valn articles

VALN Articles, Valneva SE - From 02/05/24

Stock Information
Company Name: Valneva SE
Stock Symbol: VALN
Market: NASDAQ
Website: valneva.com
Menu
VALN VALN Quote VALN Short VALN News VALN Articles VALN Message Board
Get VALN Alerts

News, Short Squeeze, Breakout and More Instantly...
McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday | Benzinga

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street exp...
Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum | Benzinga

Saint-Herblain (France), January 4, 2024 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announces that members of its...

Valneva Provides Updated 2023 Financial Guidance | Benzinga

Saint-Herblain (France), December 29, 2023 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that the Company ...

Valneva Says Single Chikungunya Vaccine Shows Long-Lasting Antibody Response In Younger, Older Adults | Benzinga

Valneva SE (NASDAQ: VALN) reported antibody persistence data 24 months after vaccination with a single dose of its chikungunya vaccine IXCHIQ,...
FDA Approves World's First Mosquito-Borne Chikungunya Vaccine | Benzinga

The FDA approved Valneva SE's (NASDAQ: VALN) Chikungunya single-dose vaccine in individuals aged 18 and above. The company plans...

Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference | Benzinga

Saint-Herblain (France), November 7, 2023 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that its senior ma...

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32 Million | Benzinga

Saint Herblain (France), September 25, 2023 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced the signing of a...
Pfizer, Valneva's Tick-Borne Infection Shot: Companies Say 'Positive' Result For Lyme Disease Vaccine Candidate Booster | Benzinga

Valneva SE (NASDAQ: VALN) and Pfizer Inc (NYSE: PFE) released pediatric and adolescent immunogenicity and safety data for their Lyme...

Valneva to Participate in Investor Conferences in the United States and Europe in September 2023 | Benzinga

Saint-Herblain (France), August 31, 2023 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that members of its...

Previous 10 Next 10